Scinai Immunotherapeutics Ltd - ADR

NASDAQ:SCNI

2.20

-0.07 (-2.95%)

4:43:52 PM EDT: $2.24 +0.04 (+1.68%)

Scinai Immunotherapeutics Ltd - ADR Stock, NASDAQ:SCNI

Jerusalem BioPark, Hadassah Ein Kerem Campus, Jerusalem, Jerusalem 74036

Israel

Phone: +972.302.930.2529

Number of Employees: 31

http://www.scinai.com

Description

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.